S 1250
118th Congress
Senate
Health
Administrative law and regulatory procedures
Civil actions and liability
Department of Health and Human Services
Health care costs and insurance
Marketing and advertising
Prescription drugs
Drug-price Transparency for Consumers Act of 2023
Introduced: April 20, 2023
Introduced by:
Durbin, Richard J.
Democratic
· Illinois
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 20, 2023
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298)
Apr 20, 2023
Introduced in Senate
Plain-English summary
Drug-price Transparency for Consumers Act of 2023 or the DTC Act of 2023
This bill requires consumer advertisements for drugs and biologicals to include certain price information if the drug or biological is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law. The requirement does not apply to advertisements for drugs or biologicals with a wholesale cost of less than $35 for a one-month supply.
Each violation of this requirement is subject to a civil penalty of not more than $100,000.
What's happening now
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298)
Committees of jurisdiction
1